Check medicine names and approval
The Food and Drug Administration (FDA), a US agency, handles medicine reviews.
Semaglutide products Ozempic and Wegovy, along with tirzepatide products Mounjaro and Zepbound, have FDA approval as of September 2026.
Ozempic injection's approval covers controlling blood sugar for adults living with type 2 diabetes.
Wegovy's approved uses cover losing weight and maintaining the loss, together with changes in diet and physical activity.
Ask whether you would take it as a shot, a tablet or another way. Ask why that exact product fits your health problem.
Made to order does not mean an approved copy
For a compounded medicine, a patient's particular needs shape what the pharmacist or doctor prepares.
Generic describes a medicine with approval as a copy of a named brand's product.
As of September 2026, no generic semaglutide or tirzepatide had FDA approval allowing US sale.
A semaglutide copy had only tentative approval: it met FDA standards but could not yet be sold.
Ask a service to explain what it means by the word.
Calling a compounded medicine equivalent to an approved drug is misleading, the FDA says as of September 2026.
It also warns against claims that studies in people proved the compounded medicine gives the same results.
Some familiar online names have no approval
BPC-157, ipamorelin and retatrutide had no US medicine approval in FDA records as of September 2026.
As of September 2026, the FDA states that retatrutide cannot be used for compounding under federal law.
A study title, a record in an online list or a polished description can leave the main question unanswered. Request the record showing approval for that particular product.
Write the answer in ordinary words
- Medicine name and how I would take it: shot, tablet or another way
- Problem it is meant to treat
- Approved product or medicine made to order
- Reason this option fits my health needs
- Name of the pharmacy that would supply it
If the explanation still feels vague, bring it back to these points. A treatment name is the start of a discussion.
Read about compoundingRead a treatment claim